These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Solution Conformations Explain the Chameleonic Behaviour of Macrocyclic Drugs. Danelius E; Poongavanam V; Peintner S; Wieske LHE; Erdélyi M; Kihlberg J Chemistry; 2020 Apr; 26(23):5231-5244. PubMed ID: 32027758 [TBL] [Abstract][Full Text] [Related]
4. "Flexible-Acceptor" General Solubility Equation for beyond Rule of 5 Drugs. Avdeef A; Kansy M Mol Pharm; 2020 Oct; 17(10):3930-3940. PubMed ID: 32787270 [TBL] [Abstract][Full Text] [Related]
5. Macrocycles in Drug Discovery─Learning from the Past for the Future. Garcia Jimenez D; Poongavanam V; Kihlberg J J Med Chem; 2023 Apr; 66(8):5377-5396. PubMed ID: 37017513 [TBL] [Abstract][Full Text] [Related]
6. Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties? Giordanetto F; Kihlberg J J Med Chem; 2014 Jan; 57(2):278-95. PubMed ID: 24044773 [TBL] [Abstract][Full Text] [Related]
7. ADME evaluation in drug discovery. 5. Correlation of Caco-2 permeation with simple molecular properties. Hou TJ; Zhang W; Xia K; Qiao XB; Xu XJ J Chem Inf Comput Sci; 2004; 44(5):1585-600. PubMed ID: 15446816 [TBL] [Abstract][Full Text] [Related]
9. Predicting the Permeability of Macrocycles from Conformational Sampling - Limitations of Molecular Flexibility. Poongavanam V; Atilaw Y; Ye S; Wieske LHE; Erdelyi M; Ermondi G; Caron G; Kihlberg J J Pharm Sci; 2021 Jan; 110(1):301-313. PubMed ID: 33129836 [TBL] [Abstract][Full Text] [Related]
10. Flexibility in early drug discovery: focus on the beyond-Rule-of-5 chemical space. Caron G; Digiesi V; Solaro S; Ermondi G Drug Discov Today; 2020 Apr; 25(4):621-627. PubMed ID: 31991117 [TBL] [Abstract][Full Text] [Related]
11. Conformational Sampling of Macrocyclic Drugs in Different Environments: Can We Find the Relevant Conformations? Poongavanam V; Danelius E; Peintner S; Alcaraz L; Caron G; Cummings MD; Wlodek S; Erdelyi M; Hawkins PCD; Ermondi G; Kihlberg J ACS Omega; 2018 Sep; 3(9):11742-11757. PubMed ID: 30320271 [TBL] [Abstract][Full Text] [Related]
12. Updating the portfolio of physicochemical descriptors related to permeability in the beyond the rule of 5 chemical space. Ermondi G; Vallaro M; Goetz G; Shalaeva M; Caron G Eur J Pharm Sci; 2020 Apr; 146():105274. PubMed ID: 32088315 [TBL] [Abstract][Full Text] [Related]
13. ADME properties evaluation in drug discovery: in silico prediction of blood-brain partitioning. Zhu L; Zhao J; Zhang Y; Zhou W; Yin L; Wang Y; Fan Y; Chen Y; Liu H Mol Divers; 2018 Nov; 22(4):979-990. PubMed ID: 30083853 [TBL] [Abstract][Full Text] [Related]
14. In silico prediction of blood-brain barrier permeation using the calculated molecular cross-sectional area as main parameter. Gerebtzoff G; Seelig A J Chem Inf Model; 2006; 46(6):2638-50. PubMed ID: 17125204 [TBL] [Abstract][Full Text] [Related]
15. Managing Experimental 3D Structures in the Beyond-Rule-of-5 Chemical Space: The Case of Rifampicin. Ermondi G; Lavore F; Vallaro M; Tiana G; Vasile F; Caron G Chemistry; 2021 Jul; 27(40):10394-10404. PubMed ID: 34114271 [TBL] [Abstract][Full Text] [Related]
16. Prediction of bioconcentration factors in fish and invertebrates using machine learning. Miller TH; Gallidabino MD; MacRae JI; Owen SF; Bury NR; Barron LP Sci Total Environ; 2019 Jan; 648():80-89. PubMed ID: 30114591 [TBL] [Abstract][Full Text] [Related]
17. Can small drugs predict the intrinsic aqueous solubility of 'beyond Rule of 5' big drugs? Avdeef A; Kansy M ADMET DMPK; 2020; 8(3):180-206. PubMed ID: 35300304 [TBL] [Abstract][Full Text] [Related]
18. Direct Comparison of the Prediction of the Unbound Brain-to-Plasma Partitioning Utilizing Machine Learning Approach and Mechanistic Neuropharmacokinetic Model. Kosugi Y; Mizuno K; Santos C; Sato S; Hosea N; Zientek M AAPS J; 2021 May; 23(4):72. PubMed ID: 34008121 [TBL] [Abstract][Full Text] [Related]
19. Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-Up Approach Using In Vitro Assay. Kosugi Y; Hosea N Mol Pharm; 2020 Jul; 17(7):2299-2309. PubMed ID: 32478525 [TBL] [Abstract][Full Text] [Related]
20. Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates. Doak BC; Over B; Giordanetto F; Kihlberg J Chem Biol; 2014 Sep; 21(9):1115-42. PubMed ID: 25237858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]